Cargando…
Effectiveness of long-term infliximab use and impact of treatment adherence on disease control in refractory, non-infectious pediatric uveitis
BACKGROUND: Refractory non-infectious uveitis is a serious condition that leads to ocular complications and vision loss and requires effective systemic treatment to control disease. The effectiveness of long-term infliximab [IFX] in refractory non-infectious childhood uveitis and the impact of treat...
Autores principales: | Miraldi Utz, Virginia, Bulas, Sabrina, Lopper, Sarah, Fenchel, Matthew, Sa, Ting, Mehta, Mitul, Ash, Daniel, Lovell, Daniel J., Kaufman, Adam H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884783/ https://www.ncbi.nlm.nih.gov/pubmed/31783768 http://dx.doi.org/10.1186/s12969-019-0383-9 |
Ejemplares similares
-
AAPOS Pediatric Uveitis Committee: COVID-19—infection, inflammation, and challenges in children with noninfectious uveitis
por: Bohnsack, Brenda, et al.
Publicado: (2022) -
Infliximab in the treatment of refractory uveitis. Does dose really matter?
por: Sukumaran, MD Sukesh, et al.
Publicado: (2011) -
High Dose Infliximab in the Treatment of Refractory Uveitis: Does Dose Matter?
por: Sukumaran, Sukesh, et al.
Publicado: (2012) -
A 10-year follow-up of infliximab monotherapy for refractory uveitis in Behçet’s syndrome
por: Horiguchi, Noe, et al.
Publicado: (2020) -
The Efficacy and Safety of Infliximab in Refractory Noninfectious Uveitis: A Meta-Analysis of Observational Studies
por: Xiong, Anji, et al.
Publicado: (2021)